相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Abuse Rates and Routes of Administration of Reformulated Extended-Release Oxycodone: Initial Findings From a Sentinel Surveillance Sample of Individuals Assessed for Substance Abuse Treatment
Stephen F. Butler et al.
JOURNAL OF PAIN (2013)
Impact of Intravenous Naltrexone on Intravenous Morphine-Induced High, Drug Liking, and Euphoric Effects in Experienced, Nondependent Male Opioid Users
Lynn R. Webster et al.
Drugs in research & development (2013)
Effects of Alcohol on the Pharmacokinetics of Morphine Sulfate and Naltrexone Hydrochloride Extended Release Capsules
Franklin K. Johnson et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
The Relative Bioavailability of Morphine Sulfate and Naltrexone Hydrochloride Extended Release Capsules (EMBEDA (R)) and an Extended Release Morphine Sulfate Capsule Formulation (KADIAN (R)) in Healthy Adults Under Fasting Conditions
Franklin K. Johnson et al.
AMERICAN JOURNAL OF THERAPEUTICS (2011)
Sustained-release morphine sulfate with sequestered naltrexone for moderate to severe pain: a new opioid analgesic formulation and beyond
Xiulu Ruan
EXPERT OPINION ON PHARMACOTHERAPY (2011)
Morphine sulfate and naltrexone hydrochloride extended release capsules for the management of chronic, moderate-to-severe pain, while reducing morphine-induced subjective effects upon tampering by crushing
Howard S. Smith
EXPERT OPINION ON PHARMACOTHERAPY (2011)
Tampering with Prescription Opioids: Nature and Extent of the Problem, Health Consequences, and Solutions
Nathaniel Katz et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2011)
Severe Opioid Withdrawal Due to Misuse of New Combined Morphine and Naltrexone Product (Embeda)
David H. Jang et al.
ANNALS OF EMERGENCY MEDICINE (2010)
Relative Oral Bioavailability of Morphine and Naltrexone Derived From Crushed Morphine Sulfate and Naltrexone Hydrochloride Extended-Release Capsules Versus Intact Product and Versus Naltrexone Solution: A Single-Dose, Randomized-Sequence, Open-Label, Three-Way Crossover Trial in Healthy Volunteers
Franklin K. Johnson et al.
CLINICAL THERAPEUTICS (2010)
Opioid Formulations Designed to Resist/Deter Abuse
Robert B. Raffa et al.
DRUGS (2010)
ALO-01 (Morphine Sulfate and Naltrexone Hydrochloride) Extended-Release Capsules in the Treatment of Chronic Pain of Osteoarthritis of the Hip or Knee: Pharmacokinetics, Efficacy, and Safety
Nathaniel Katz et al.
JOURNAL OF PAIN (2010)
The Prevalence of Chronic Pain in United States Adults Results of an Internet-Based Survey
Catherine B. Johannes et al.
JOURNAL OF PAIN (2010)
Long-Term Safety and Efficacy of Morphine Sulfate and Naltrexone Hydrochloride Extended Release Capsules, a Novel Formulation Containing Morphine and Sequestered Naltrexone, in Patients with Chronic, Moderate to Severe Pain
Lynn R. Webster et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2010)
Ultra-low dose naltrexone attenuates chronic morphine-induced gliosis in rats
Theresa-Alexandra M. Mattioli et al.
MOLECULAR PAIN (2010)
A Flood of Opioids, a Rising Tide of Deaths
Susan Okie
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Morphine Sulfate and Naltrexone Hydrochloride Extended Release Capsules in Patients with Chronic Osteoarthritis Pain
Nathaniel Katz et al.
POSTGRADUATE MEDICINE (2010)
Human abuse liability assessment of oxycodone combined with ultra-low-dose naltrexone
David Andrew Tompkins et al.
PSYCHOPHARMACOLOGY (2010)
The Role of Urine Drug Testing for Patients on Opioid Therapy
Joseph Pergolizzi et al.
PAIN PRACTICE (2010)
Subjective Effects and Safety of Whole and Tampered Morphine Sulfate and Naltrexone Hydrochloride (ALO-01) Extended-Release Capsules versus Morphine Solution and Placebo in Experienced Non-Dependent Opioid Users A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
Joseph Stauffer et al.
CLINICAL DRUG INVESTIGATION (2009)
Epidemiology of chronic pain in Denmark: An update
Per Sjogren et al.
EUROPEAN JOURNAL OF PAIN (2009)
The clinical efficacy and abuse potential of combination buprenorphive-naloxone in the treatment of opioid dependence
Kristie Mammen et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
The impact of pain on quality of life and the unmet needs of pain management: Results from pain sufferers and physicians participating in an Internet survey
Bill H. McCarberg et al.
AMERICAN JOURNAL OF THERAPEUTICS (2008)
Oxytrex®:: an oxycodone and ultra-low-dose naltrexone formulation
Lynn R. Webster
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Inhibition of tolerance to spinal morphine antinociception by low doses of opioid receptor antagonists
Benjamin McNaull et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Foundations of opioid risk management
Nathaniel P. Katz et al.
CLINICAL JOURNAL OF PAIN (2007)
The coexistence of neuropathic pain, sleep, and psychiatric disorders - A novel treatment approach
Charles E. Argoff
CLINICAL JOURNAL OF PAIN (2007)
Oxytrex minimizes physical dependence while providing effective analgesia: A randomized controlled trial in low back pain
Lynn R. Webster et al.
JOURNAL OF PAIN (2006)
Concerns about medication and medication use in chronic pain
Lance M. McCracken et al.
JOURNAL OF PAIN (2006)
Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment
H Breivik et al.
EUROPEAN JOURNAL OF PAIN (2006)
Ultra-low-dose naltrexone reduces the rewarding potency of oxycodone and relapse vulnerability in rats
F Leri et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
Ultra-low-dose naltrexone suppresses rewarding effects of opiates and aversive effects of opiate withdrawal in rats
MC Olmstead et al.
PSYCHOPHARMACOLOGY (2005)
Adding ultralow-dose naltrexone to oxycodone enhances and prolongs analgesia: A randomized, controlled trial of oxytrex
VL Chindalore et al.
JOURNAL OF PAIN (2005)
Prevalence and characteristics of chronic pain in the general Norwegian population
T Rustoen et al.
EUROPEAN JOURNAL OF PAIN (2004)
The clinical opiate withdrawal scale (COWS)
DR Wesson et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2003)
Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats
KJ Powell et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
分享论文
